Other
Sponsor ID
AMG714 Expanded Access Program
AMG 714 Expanded Access Program
Study Details
Expanded access requests for AMG 714 may be considered for adult patients with biopsy proven Refractory Celiac Disease Type II who have failed all available treatment options and do not have EATL. To request access, use Responsible Party contact information provided in this record.
Protocol Summary
Primary Outcome Measures
Not Available
Secondary Outcome Measures
Not Available
Locations
No locations found.